Fischer Medical Ventures Limited (NSE:FISCHER)
India · Delayed Price · Currency is INR 34.77
-0.26 (-0.74%)
Sep 24, 2026, 11:53 AM IST
Fischer Medical Ventures Revenue
Fischer Medical Ventures had revenue of 819.20M INR in the quarter ending June 30, 2026, with 249.42% growth. This brings the company's revenue in the last twelve months to 3.67B, up 195.95% year-over-year. In the fiscal year ending March 31, 2026, Fischer Medical Ventures had annual revenue of 3.09B with 178.75% growth.
Revenue (ttm)
3.67B
Revenue Growth
+195.95%
P/S Ratio
6.25
Revenue / Employee
229.41M
Employees
16
Market Cap
22.93B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.09B | 1.98B | 178.75% |
| Mar 31, 2025 | 1.11B | 897.17M | 427.61% |
| Mar 31, 2024 | 209.81M | 208.02M | 11,588.75% |
| Mar 31, 2023 | 1.80M | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Apollo Hospitals Enterprise | 264.30B |
| Divi's Laboratories | 112.30B |
| Lenskart Solutions | 96.34B |
| Indoco Remedies | 18.73B |
| Medi Assist Healthcare Services | 9.51B |
| Windlas Biotech | 9.42B |
| Panacea Biotec | 6.73B |
Fischer Medical Ventures News
- 1 year ago - Fischer Medical Ventures launches Chennai’s first high-resolution open MRI at Sunray Scans - Business Upturn